Related Experiment Video
Updated: Oct 6, 2025

09:27
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
Published on: January 5, 2016
17.6K
Genotype-phenotype correlations in alpha-sarcoglycanopathy: a systematic review.
Luke Carson1, Deborah Merrick2
1School of Life Sciences, University of Nottingham, Nottingham, UK. luke.carson1@nhs.net.
Irish Journal of Medical Science
|January 18, 2022
Summary
Mutations in alpha-sarcoglycan cause limb-girdle muscular dystrophy 2D. This study found mutation hotspots and linked specific mutations, like those in exon three, to cardiac issues and severe phenotypes, aiding personalized medicine.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Limb-girdle muscular dystrophy 2D (LGMD2D) is an autosomal recessive disorder caused by mutations in the alpha-sarcoglycan gene.
- Previous research has not comprehensively cataloged alpha-sarcoglycan mutations and their corresponding phenotypes.
- This study aims to correlate mutation locations and types with clinical manifestations in LGMD2D.
Approach:
- A systematic literature review was conducted to gather all reported mutations in the alpha-sarcoglycan gene.
- Genotype-phenotype data from 134 unique genotypes were analyzed.
- Statistical analysis was used to identify mutation hotspots and significant variations in mutation densities.
Key Points:
- Missense mutations constitute 64% of all identified alpha-sarcoglycan mutations.
- Mutation hotspots were identified in exon three and the extracellular domain.
- All compound heterozygous LGMD2D patients with cardiac involvement had at least one mutation in exon three.
- Nonsense mutations and combinations involving exons four and five result in severe phenotypes.
- The high prevalence of the c.229C>T mutation was confirmed.
Conclusions:
- Significant variation in disease severity exists even among patients with identical mutations, complicating genotype-phenotype correlations in LGMD2D.
- The association of exon three mutations with cardiomyopathy in compound heterozygous patients is a novel finding.
- Identifying mutation hotspots and specific mutation types (e.g., involving exons four and five) can inform diagnostic and therapeutic strategies for personalized medicine.
Related Concept Videos
Lysosomal Hydrolases
4.0K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
84
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
84
Proteoglycans
4.1K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K
Multiple Allele Traits
35.8K
The Concept of Multiple Allelism
35.8K

